A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein

Human Gene Therapy

Volumn 22, Issue 2, 2011, Pages 197-206

  Kato, Shigeki ^a,b   Kobayashi, Kenta ^a   Inoue, Ken Ichi ^c   Kuramochi, Masahito ^a   Okada, Tomoaki ^a   Yaginuma, Hiroyuki ^a   Morimoto, Kinjiro ^d,e   Shimada, Takashi ^f   Takada, Masahiko ^b,c   Kobayashi, Kazuto ^a,b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e YASUDA WOMEN'S UNIVERSITY   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; EXPERIMENTAL MONKEY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INJECTION SITE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PROTEIN DOMAIN; PSEUDOTYPING; PUTAMEN; RETROGRADE NERVE FIBER TRANSPORT; TRANSGENE; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, VIRAL; CORPUS STRIATUM; GENE THERAPY; GENETIC VECTORS; GLYCOPROTEINS; HEK293 CELLS; HIV-1; HUMANS; MACACA FASCICULARIS; MICE; MICE, INBRED C57BL; RABIES VIRUS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; RABIES VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 79951848645     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.179     Document Type: Article

References (48)

1. Azzouz, M., Kingsman, S.M., and Mazarakis, N.D. (2004a). Lentiviral ve (Pubitemid 40228110)
2. Azzouz, M., Ralph, G.S., Storkebaum, E., Walmsley, L.E., Mitrophanous, K.A., Kingsman, S.M., Carmellet, P., and Mazarakis, N.D. (2004b). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413-417. (Pubitemid 38715132)
3. Barkats, M., Horellou, P., Colin, P., Millecamps, S., Faucon-Biguet, N., and Mallet, J. (2006). 1-Methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase. J. Neurosci. Res. 83, 233-242. (Pubitemid 43184387)
4. Baumgartner, B.J., and Shine, H.D. (1998). Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp. Neurol. 153, 102-112. (Pubitemid 28452301)
5. Brog, J.S., Salyapongse, A., Deutch, A.Y., and Zahm, D.S. (1993). The patterns of afferent innervations of the core and shell in the "accumbens" part of the rat ventral striatum: Im-munohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338, 255-278. (Pubitemid 23339283)
6. Cosson, P. (1996). Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15, 5783-5788. (Pubitemid 26375499)
7. Cronin, J., Zhang, X.-Y., and Reiser, J. (2005). Altering the tro-pism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5, 387-398. (Pubitemid 41052430)
8. Federici, T., Kutner, R., Zhang, X.-Y., Kuroda, H., Tordo, N., Boulis, N.M., and Reiser, J. (2009). Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycopro-teins for neuronal gene transfer. Genet. Vaccines Ther. 7, 1.
9. Fjord-Larsen, L., Johansen, J.L., Kusk, P., Tornøe, J., Grønborg M., Rosenblad, C., and Wahlberg, L.U. (2005). Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Exp. Neurol. 195, 49-60. (Pubitemid 41116813)
10. Gastja, M., Horvath, J., and Lentz, T.L. (1996). Rabies virus binding to the nicotinic acetylcholine receptor a subunit demonstrated by virus overlay protein binding assay. J. Gen. Virol. 77, 2437-2440. (Pubitemid 26348364)
11. Georgievska, B., Jakobsson, J., Persson, E., Ericson, C., Kirik, D., and Lundberg, C. (2004). Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetra-cycline-dependent lentiviral vector. Hum. Gene Ther. 15, 934-944. (Pubitemid 39372570)
12. Hanawa, H., Kelly, P.F., Nathwani, A.C., Persons, D.A., Van-dergriff, J.A., Hargrove, P., Vanin, E.F., and Nienhuis, A.W. (2002). Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol. Ther. 5, 242-251. (Pubitemid 34211219)
13. Hanawa, H., Hematti, P., Keyvanfar, K., Metzger, M.E., Krouse, A., Donahue, R.E., Kepes, S., Gray, J., Dunbar, C.E., Persons, D.A., and Nienhuis, A.W. (2004). Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103, 4062-4069. (Pubitemid 38685345)
14. Hanham, C.A., Zhao, F., and Tignor, G.H. (1993). Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor. J. Virol. 67, 530-542. (Pubitemid 23003017)
15. Jeetendra, E., Robinson, C.S., Albritton, L.M., and Whitt, M.A. (2002). The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion po-tentiator and can induce hemifusion. J. Virol. 76, 12300-12311. (Pubitemid 35304328)
16. \+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J. Virol. 71, 5060-5068. (Pubitemid 27258176)
17. Kato, S., Inoue, K., Kobayashi, K., Yasoshima, Y., Miyachi, S., Inoue, S., Hanawa, H., Shimada, T., Takada, M., and Ko-bayashi, K. (2007). Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. Hum. Gene Ther. 18, 1141-1151. (Pubitemid 350114690)
18. Kordower, J.H., Emborg, M.E., Bloch, J., Ma, S.Y., Chu, Y., Le-venthal, L., McBride, J., Chen, E.-Y., Palfi, S., Roitberg, B.Z., Brown, W.D., Holden, J.E., Pyzalski, R., Taylor, M.D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Déglon, N., and Ae-bischer, P. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773.
19. Lo Bianco, C., Schneider, B.L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T., and Aebischer, P. (2004). Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an a-synuclein rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 17510-17515. (Pubitemid 39657434)
20. Lundberg, C., Björklund, T., Carlsson, T., Jakobsson, J., Han-traye, P., Déglon, N., and Kirik, D. (2008). Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr. Gene Ther. 8, 461-473.
21. Mazarakis, N.D., Azzouz, M., Rohll, J.B., Ellard, F.M., Wilkes, F.J., Olsen, A.L., Carter, E.E., Barber, R.D., Baban, D.F., Kingsman, S.M., Kingsman, A.J., O'Malley, K., and Mi-trophanous, K.A. (2001). Rabies virus glycoprotein pseudo-typing of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121. (Pubitemid 32998823)
22. McCoy, M.K., Ruhn, K.A., Martinez, T.N., McAlpine, F.E., Blesch, A., and Tansey, M.G. (2008). Intranigral lentiviral delivery of dopamine-negative TNF attenuates neurodegenera-tion and behavioral deficits in hemiparkinsonian rats. Mol. Ther. 16, 1572-1579.
23. McIntyre, D.C., Kelly, M.E., and Staines, W.A. (1996). Efferent projections of the anterior perirhinal cortex in the rat. J. Comp. Neurol. 369, 302-318. (Pubitemid 26152520)
24. Mentis, G.Z., Gravell, M., Hamilton, R., Shneider, N.A., O'Do-novan, M.J., and Schubert, M. (2006). Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glyco-proteins. J. Neurosci. Methods 157, 208-217. (Pubitemid 44339638)
25. Mitrophanous, K.A., Yoon, S., Rohill, J.B., Patil, D., Wilkes, F.J., Kim, V.N., Kingsman, S.M., Kingsman, A.J., and Mazarakis, N.D. (1999). Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808-1818. (Pubitemid 29531276)
26. Mochizuki, H., Schwartz, J.P., Tanaka, K., Brady, R.O., and Reiser, J. (1998). High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondivid-ing cells. J. Virol. 72, 8873-8883. (Pubitemid 28471831)
27. Morimoto, K., Hooper, D.C., Carbaugh, H., Fu, Z.F., Koprowski, H., and Dietzschold, B. (1998). Rabies virus quasispecies: Implications for pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 95, 3152-3156. (Pubitemid 28135870)
28. Naldini, L., Blömer, U., Gage, F.H., Trono, D., and Verma, I.M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388. (Pubitemid 26347130)
29. Niwa, H., Yamamura, K., and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eu-karyotic vector. Gene 108, 193-199.
30. Owens, R.J., and Rose, J.K. (1993). Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J. Virol. 67, 360-365. (Pubitemid 23002998)
31. Paxinos, G., and Franklin, K.B.J. (2001). The Mouse Brain in Ste-reotaxic Coordinates, 2nd edn. (Academic Press, San Diego).
32. Perrelet, D., Ferri, A., Mackenzie, A.E., Smith, G.M., Korneluk, R.G., Liston, P., Sagot, Y., Terrado, J., Monnier, D., and Kato, A.C. (2000). IAP family proteins delay motoneuron cell death in vivo. Eur. J. Neurosci. 12, 2059-2067. (Pubitemid 30348843)
33. Reiser, J., Harmison, G., Kluepfel-Stahl, S., Brady, R.O., Karls-son, S., and Schubert, M. (1996). Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. U.S.A. 93, 15266-15271.
34. Ridet, J.L., Bensadoun, J.C., Déglon, N., Aebischer, P., and Zurn, A.D. (2006). Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's disease. Neurobiol. Dis. 21, 29-34. (Pubitemid 41817302)
35. Robison, C.S., and Whitt, M.A. (2000). The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J. Virol. 74, 2239-2246. (Pubitemid 30091478)
36. Rose, J.K., Doolittle, R.F., Anilionis, A., Curtis, P.J., and Wunner, W.H. (1982). Homology between the glycoproteins of vesicular stomatitis virus and rabies virus. J. Virol. 43, 361-364. (Pubitemid 12084918)
37. Sapru, M.K., Yates, J.W., Hogan, S., Jiang, L., Halter, J., and Bohn, M.C. (2006). Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Exp. Neurol. 198, 382-390.
38. Schnell, M.J., Buonocore, L., Boritz, E., Ghosh, H.P., Chernish, R., and Rose, J.K. (1998). Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J. 17, 1289-1296. (Pubitemid 28105508)
39. Simons, K., and Garoff, H. (1980). The budding mechanisms of enveloped animal viruses. J. Gen. Virol. 50, 1-21.
40. Stephens, E.B., and Compans, R.W. (1988). Assembly of animal viruses at cellular membranes. Annu. Rev. Microbiol. 42, 489-516. (Pubitemid 19179306)
41. Szabo, J. and Cowan, W.M. (1984). A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J. Comp. Neurol. 222, 265-300. (Pubitemid 14178837)
42. Thoulouze, M.-I., Lafage, M., Schachner, M., Hartmann, U., Cremer, H., and Lafon, M. (1998). The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72, 7181-7190. (Pubitemid 28377847)
43. Tuffereau, C., Bénéjean, J., Blondel, D., Kieffer, B., and Flamand, A. (1998). Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17, 7250-7259. (Pubitemid 29002694)
44. Vercammen, L., Van der Perren, A., Vaudano, E., Gijsbers, R., Debyser, Z., Van den Haute, C., and Baekelandt, V. (2006). Parkin protects against neurotoxicity in the 6-hydro-xydopamine rat model for Parkinson's disease. Mol. Ther. 14, 716-723. (Pubitemid 44507714)
45. Vertes, R.P. (2004). Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51, 32-58. (Pubitemid 37421138)
46. Witt, M.A., Chong, L., and Rose, J.K. (1989). Glycoprotein cy-toplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J. Virol. 63, 3569-3578. (Pubitemid 19205425)
47. Wong, L.F., Goodhead, L., Prat, C., Mitrophanous, K.A., Kingsman, S.M., and Mazarakis, N.D. (2006). Lentivirus-mediated gene transfer to the central nervous system: Therapeutic and research applications. Hum. Gene Ther. 17, 1-9. (Pubitemid 43102718)
48. Zheng, J.S., Tang, L.L., Zheng, S.S., Zhan, R.Y., Zhou, Y.Q., Goudreau, J., Kaufman, D., and Chen, A.F. (2005). Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Brain Res. Mol. Brain Res. 134, 155-161. (Pubitemid 40403647)